AGE MANAGEMENT THERAPEUTICS Trademark
Trademark Overview
On Thursday, June 12, 2003, a trademark application was filed for AGE MANAGEMENT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AGE MANAGEMENT THERAPEUTICS trademark a serial number of 78261650. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 24, 2015. This trademark is owned by UNIFUND CORPORATION LIMITED. The AGE MANAGEMENT THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:
Medicinal preparations, sold only by prescription, in the form of powders used as a neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer for the elimination of anxiety and hyperactivity, mitigation of panic symptomology, reduction of fatigue, improvement of self-confidence and self-esteem, elimination of the need for anti-depressants, cognitive enhancement, improvement of aerobic endurance and performance and weight-training capacity, improvement of blood circulation, reduction of blood pressure and hypertension, improvement of sexual performance and libido, reduction of hormonal imbalance in menopausal and post-menopausal women, improvement of visual and auditory acuity, improvement of physical agility and muscle flexibility, improvement of social interaction skills, promotion of relaxation response and mitigation of chronic sleep pattern disorders such as insomnia and other chronic sleep disorders, reduction of arthritic pain and swelling, e...
General Information
Serial Number | 78261650 |
Word Mark | AGE MANAGEMENT THERAPEUTICS |
Filing Date | Thursday, June 12, 2003 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Friday, April 24, 2015 |
Registration Number | 2888015 |
Registration Date | Tuesday, September 21, 2004 |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Medicinal preparations, sold only by prescription, in the form of powders used as a neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer for the elimination of anxiety and hyperactivity, mitigation of panic symptomology, reduction of fatigue, improvement of self-confidence and self-esteem, elimination of the need for anti-depressants, cognitive enhancement, improvement of aerobic endurance and performance and weight-training capacity, improvement of blood circulation, reduction of blood pressure and hypertension, improvement of sexual performance and libido, reduction of hormonal imbalance in menopausal and post-menopausal women, improvement of visual and auditory acuity, improvement of physical agility and muscle flexibility, improvement of social interaction skills, promotion of relaxation response and mitigation of chronic sleep pattern disorders such as insomnia and other chronic sleep disorders, reduction of arthritic pain and swelling, enhancement of immune system functioning, improvement of the metabolism, relief from constipation, improvement of skin tone, mitigation of "jet lag," and reduction in caffeine dependence; and the treatment of a broad spectrum of conditions and pathologies, namely, age-related and neuro-degenerative conditions and pathologies, nerve diseases, general anxiety disorder, depression, neurosis, neurasthenia, obsessive-compulsive disorder, chronic sleep disorder, chronic fatigue syndrome, digestive diseases, chronic constipation, hypertension, osteoarthritis pain and swelling, and human sexual desire disorder |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, April 24, 2015 |
Primary Code | 005 |
First Use Anywhere Date | Sunday, April 7, 2002 |
First Use In Commerce Date | Wednesday, April 10, 2002 |
Trademark Owner History
Party Name | UNIFUND CORPORATION |
Party Type | 31 - New Owner After Registration |
Legal Entity Type | 03 - Corporation |
Address | BEVERLY HILLS, CA 90210 |
Party Name | UNIFUND CORPORATION LIMITED |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | LONDON E1 6EU GB |
Party Name | UNIFUND CORPORATION LIMITED |
Party Type | 11 - New Owner Before Publication |
Legal Entity Type | 03 - Corporation |
Address | LONDON E1 6EU GB |
Party Name | NOT AVAILABLE |
Party Type | 10 - Original Applicant |
Legal Entity Type | 01 - Individual |
Address | Los Angeles, CA 90046 |
Trademark Events
Event Date | Event Description |
Friday, April 24, 2015 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
Tuesday, March 8, 2011 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Tuesday, March 8, 2011 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, March 10, 2010 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
Wednesday, March 10, 2010 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Wednesday, March 3, 2010 | TEAS SECTION 8 RECEIVED |
Wednesday, March 3, 2010 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Tuesday, March 21, 2006 | REVIEW OF CORRESPONDENCE COMPLETE |
Friday, July 22, 2005 | PAPER RECEIVED |
Monday, November 22, 2004 | SEC 7 REQUEST FILED |
Monday, November 22, 2004 | PAPER RECEIVED |
Tuesday, September 21, 2004 | REGISTERED-SUPPLEMENTAL REGISTER |
Wednesday, July 14, 2004 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
Wednesday, July 14, 2004 | EXAMINERS AMENDMENT E-MAILED |
Tuesday, June 29, 2004 | PAPER RECEIVED |
Tuesday, June 8, 2004 | AMENDMENT FROM APPLICANT ENTERED |
Tuesday, June 8, 2004 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, June 8, 2004 | PAPER RECEIVED |
Thursday, April 22, 2004 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, December 18, 2003 | NON-FINAL ACTION E-MAILED |
Tuesday, December 16, 2003 | ASSIGNED TO EXAMINER |